The Effect of Oral Administration of L-Tyrosine, Folic acid and Pyridoxine on Perphenazine Induced Catatonia in Rat

Author(s):
Ardeshir ArziArdeshir Arzi1,*, Mohsen RezaeiMohsen Rezaei1
1Department of Pharmacology, School of Pharmacy, Ahvaz University of Medical Sciences, Ahvaz, Iran

IJ Pharmaceutical Research:Vol. 2, issue 3; 167-171
Published online:Nov 20, 2010
Article type:Research Article
Received:May 01, 2003
Accepted:Aug 01, 2003
How to Cite:Arzi A, Rezaei M. The Effect of Oral Administration of L-Tyrosine, Folic acid and Pyridoxine on Perphenazine Induced Catatonia in Rat. Iran J Pharm Res. 2022;2(3):e127960. doi: https://doi.org/10.22037/ijpr.2010.42

Abstract

Similar Articles

30
Mar
2007

THE EFFECT OF L-TYROSINE, VITAMINS E AND C ON PERPHENAZINE-INDUCED CATATONIA IN RAT

A Arzi,
AA Hemmati,
S Ghobishavi,
L Arzi

Arzi A, Hemmati A, Ghobishavi S, Arzi L. THE EFFECT OF L-TYROSINE, VITAMINS E AND C ON PERPHENAZINE-INDUCED CATATONIA IN RAT. Jundishapur J Nat Pharm Prod. 2007;2(1):. doi:

20
Dec
2006

THE EFFECT OF SELEGILINE AND BROMOCRIPTINE IN THE PROPHYLAXIS OF PERPHENAZINE-INDUCED PSEUDOPARKINSONISM IN RAT: A COMPARATIVE STUDY

A Arzi,
A.A Hemmati,
M.H Pipelzadeh,
S.M Latifi,
F Ramesh

Arzi A, Hemmati A, Pipelzadeh M, Latifi S, Ramesh F. THE EFFECT OF SELEGILINE AND BROMOCRIPTINE IN THE PROPHYLAXIS OF PERPHENAZINE-INDUCED PSEUDOPARKINSONISM IN RAT: A COMPARATIVE STUDY. Jundishapur J Nat Pharm Prod. 2006;1(1):. doi:

12
Aug
2025
J Rep Pharm Sci

Behavioral Outcomes and Histopathological Alterations in a Rotenone-induced Parkinson’s Disease Model: A Comparative Study of L-Dopa and Apomorphine

Sayed Mostafa Modarres Mousavi,
Fatemeh Alipour,
Shima Lotfollahzadeh,
Faezeh Mousazadeh,
Hasan Hosseini,
Saman Hosseinkhani
,et al.

Modarres Mousavi SM, Alipour F, Lotfollahzadeh S, Mousazadeh F, Hosseini H, et al. Behavioral Outcomes and Histopathological Alterations in a Rotenone-induced Parkinson’s Disease Model: A Comparative Study of L-Dopa and Apomorphine. J Rep Pharm Sci. 2025;13(1):e162472. doi: https://doi.org/10.5812/jrps-162472

22
Jul
2015

Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats

M Sofiabadi,
hashem haghdoost-yazdi,
M Mahmudi,
H Pri,
T Dargahi,
M Yaghubidust

Sofiabadi M, haghdoost-yazdi H, Mahmudi M, Pri H, Dargahi T, et al. Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats. J Inflamm Dis. 2024;19(2):e155895. doi:

13
Jul
2016

Effect of potassium channel blocker of Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson\'s disease in rats

Hashem Haghdoost-Yazdi,
Soheila sehat bakhsh,
Mohammad Sofiabadi,
Tahereh Dargahi,
MH Yaghubidust,
Hossein Piri

Haghdoost-Yazdi H, sehat bakhsh S, Sofiabadi M, Dargahi T, Yaghubidust M, et al. Effect of potassium channel blocker of Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson\'s disease in rats. J Inflamm Dis. 2024;20(2):e155962. doi:


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC